Assignee
AERIE PHARMACEUTICALS INC
US·54 granted patents·23 pending applications·714 citations·filing 2006–2023
Top patents by PatentIndex Score
77 records- 0199US10174017B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2018·Granted Jan 8, 2019·41 cites·31 claims
- 0298US11197853B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2021·Granted Dec 14, 2021·5 cites·22 claims
- 0398US11185538B2Compositions for treating glaucoma or reducing intraocular pressureAERIE PHARMACEUTICALS INC·Filed 2021·Granted Nov 30, 2021·5 cites·22 claims
- 0498US11028081B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jun 8, 2021·6 cites·24 claims
- 0598US10112920B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Oct 30, 2018·20 cites·22 claims
- 0698US9884840B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2016·Granted Feb 6, 2018·25 cites·6 claims
- 0798US9643927B1Process for the preparation of kinase inhibitors and intermediates thereofAERIE PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·33 cites·22 claims
- 0898US9096569B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2014·Granted Aug 4, 2015·40 cites·36 claims
- 0998US8716310B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2013·Granted May 6, 2014·49 cites·12 claims
- 1098US7671205B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2007·Granted Mar 2, 2010·61 cites·3 claims
- 1197US11312700B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2020·Granted Apr 26, 2022·6 cites·28 claims
- 1297US10899714B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jan 26, 2021·10 cites·24 claims
- 1397US9415043B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2014·Granted Aug 16, 2016·32 cites·1 claims
- 1497US8921392B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2012·Granted Dec 30, 2014·38 cites·12 claims
- 1597US8357699B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2011·Granted Jan 22, 2013·42 cites·19 claims
- 1697US8034943B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2010·Granted Oct 11, 2011·49 cites·4 claims
- 1796US11021456B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jun 1, 2021·5 cites·33 claims
- 1896US10654844B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2019·Granted May 19, 2020·11 cites·28 claims
- 1996US10316029B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·10 cites·21 claims
- 2096US9993470B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2017·Granted Jun 12, 2018·13 cites·20 claims
- 2195US10882840B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jan 5, 2021·10 cites·25 claims
- 2295US10858339B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·9 cites·3 claims
- 2395US10588901B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·9 cites·22 claims
- 2495US10532993B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2018·Granted Jan 14, 2020·9 cites·25 claims
- 2595US9963432B2Beta-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2017·Granted May 8, 2018·10 cites·6 claims
- 2695US9951059B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2017·Granted Apr 24, 2018·10 cites·6 claims
- 2795US9931336B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·11 cites·21 claims
- 2894US11020385B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jun 1, 2021·7 cites·8 claims
- 2993US9849122B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·7 cites·21 claims
- 3093US7470787B2Isoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2006·Granted Dec 30, 2008·55 cites·26 claims
- 3192US11590123B2Ophthalmic compositionsAERIE PHARMACEUTICALS INC·Filed 2022·Granted Feb 28, 2023·1 cites·16 claims
- 3292US10568878B2Combination therapyAERIE PHARMACEUTICALS INC·Filed 2018·Granted Feb 25, 2020·6 cites·28 claims
- 3392US9512101B2Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·6 cites·16 claims
- 3492US9365518B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2014·Granted Jun 14, 2016·10 cites·21 claims
- 3591US11618748B2Dual mechanism inhibitors for the treatment of diseaseAERIE PHARMACEUTICALS INC·Filed 2021·Granted Apr 4, 2023·1 cites·24 claims
- 3691US10472327B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Nov 12, 2019·6 cites·13 claims
- 3791US8765166B2Drug delivery devices for delivery of ocular therapeutic agentsAERIE PHARMACEUTICALS INC·Filed 2013·Granted Jul 1, 2014·14 cites·16 claims
- 3890US11389441B2Ophthalmic compositionsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Jul 19, 2022·6 cites·3 claims
- 3990US9890123B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2016·Granted Feb 13, 2018·5 cites·11 claims
- 4089US11850221B2Ophthalmic pharmaceutical compositions and uses thereofAERIE PHARMACEUTICALS INC·Filed 2022·Granted Dec 26, 2023·1 cites·32 claims
- 4186US11427563B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Aug 30, 2022·2 cites·32 claims
- 4285US10849656B2Implant applicators and methods of administering implantsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Dec 1, 2020·10 cites·21 claims
- 4385US10624904B2Intravitreal drug delivery systems for the treatment of ocular conditionsAERIE PHARMACEUTICALS INC·Filed 2016·Granted Apr 21, 2020·4 cites·10 claims
- 4484US11059789B2Isoquinoline-steroid conjugates and uses thereofAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jul 13, 2021·1 cites·30 claims
- 4581US11707460B2Ophthalmic compositionsAERIE PHARMACEUTICALS INC·Filed 2022·Granted Jul 25, 2023·0 cites·29 claims
- 4681US2022088000A1Combination therapyAERIE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4778US12018012B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·0 cites·23 claims
- 4878US2021253547A1Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compoundsAERIE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4977US2022304995A1Ophthalmic compositionsAERIE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 5076US11116776B2Intravitreal drug delivery systems for the treatment of ocular conditionsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Sep 14, 2021·2 cites·26 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →